Targeted & Immunotherapy for Esophageal Cancer: Are We There Yet? Is Immune Checkpoint Inhibition Without Chemotherapy a First-Line Option for PD-L1 Expressive Tumors With High CPS?

101 views
June 25, 2021
0 Comments
Login to view comments. Click here to Login